2009-09-08 23:19:02 -
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 09/08/09 -- Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 4:05 pm ET at the New York Palace Hotel in New York City. A live webcast of the presentation will be available and can be accessed on the Company's website, www.tekmirapharm.com :
.
Dr. Murray will also participate in a panel discussion on RNAi Therapeutics at the Rodman & Renshaw conference taking place Thursday, September 10, 2009 at 8:25 am ET.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com :
. Tekmira is based in Vancouver, B.C.
Contacts:
The Equicom Group - Investors
Adam Peeler
416-815-0700 x 225
apeeler@equicomgroup.com :
Tekmira Pharmaceuticals Corporation - Investors
Ian Mortimer
Executive Vice President and Chief Financial Officer
604-419-3200
www.tekmirapharm.com :
Longview Communications Inc. - Media
David Ryan
604-694-6031
dryan@longviewcomms.ca :
